$13.03 0.03 (+0.23%)
2/9/2010 3:06 PM

Synovis Life Technologies, Inc. (SYNO)

CAPS Rating: 4 out of 5

A diversified medical device company; develops, manufactures and markets products for the surgical and interventional treatment of disease. Business is conducted in two reportable segments, the surgical business and the interventional business.

Current Price $13.03 Mkt Cap $145.75M
Open $13.19 P/E Ratio 56.52
Prev. Close $13.00 Div. (Yield) N/A (N/A)
Daily Range $12.90 - $13.19 Volume 27,282
52-Wk Range $11.16 - $21.71 Avg. Daily Vol. 0

Related News and Articles

Caps

How do you think SYNO will perform vs the S&P 500?

Add Stock to Watchlist

All Members

77 Outperform
4 Underperform
 

All-Star Members

22 Outperform
0 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top SYNO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

poinkie (99.03)
Submitted September 14, 2009

Speculating on growth from new acquisition.
$59M cash - no debt. Cash per share = $5. Renewed focus on direct sales that has proven a past successful growth model.
Pegasus acquisition will still hit expenses hard for Q4 09 & Q1 10, but… More

0 Comments | Reply | Report this Post

tenmiles (100.00)
Submitted August 29, 2007

Financial secure company with nearly $4 per share in cash, but technically likely to retrace 8-12% from current $16.30 levels; fudamentally not a "cheap one" even with 39% 3rd quarter revenue growth.

0 Comments | Reply | Report this Post
SYNO VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about SYNO.

Recs

1
Member Avatar poinkie (99.03) Submitted: 9/14/2009 12:56:43 PM : Outperform Start Price: $13.18 SYNO Score: -4.10

Speculating on growth from new acquisition.
$59M cash - no debt. Cash per share = $5. Renewed focus on direct sales that has proven a past successful growth model.
Pegasus acquisition will still hit expenses hard for Q4 09 & Q1 10, but future additional revenue & potential new market oppts should offset new Covidien competition (even though leadership is perhaps overly downplaying potential market share loss).
Bovine soft tissue treatment seems a bit gross to me, but I don't need hernia, rotator cuff, chronic wounds etc work. The addition of an equine soft tissue treatment could add lots of growth in markets where US beef isn't popular/permitted (India, China...).

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar 00100 (96.13) Submitted: 9/1/2009 3:47:53 PM : Outperform Start Price: $14.92 SYNO Score: -19.83

Upthumb. Good cash flow. Zero debt. High margins. Lots of cash. No dividend.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar jrjrook (< 20) Submitted: 5/28/2009 8:18:49 PM : Outperform Start Price: $17.62 SYNO Score: -44.56

SYNO to purchase Span-America Medical Systems, SPAN, ? Would

be a boon for both Co.s? M & A leads to growing co.s, market expansion.

Report this Post 0 Comments | Reply | Permalink
View All 10 Pitches »

Leaderboard

Find the members with the highest scoring picks in SYNO.

Score Leader

Hcurb1

Hcurb1 (98.44) Score: +73.51

The Score Leader is the member with the highest score across all their picks in SYNO.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
AGAPE1646 < 20 5/11/2007 Outperform 5Y $12.78 +1.96% -24.31% +26.26 1 Comment
HTao 56.07 5/17/2007 Outperform NS $12.89 +1.09% -25.12% +26.20
zulubaby 62.78 7/31/2009 Underperform 5Y $15.47 -15.77% +8.95% +24.73
MajBAD0437 < 20 10/2/2008 Underperform NS $17.72 -26.47% -2.78% +23.69
zinfool < 20 1/29/2007 Outperform 1Y $12.85 +1.40% -19.89% +21.29
mckx < 20 7/16/2007 Outperform NS $14.61 -10.81% -27.18% +16.36
davemb77 26.42 6/7/2007 7/24/2008 Outperform 3Y $14.36 -9.26% -24.61% +15.35
Forestboy 98.73 3/13/2007 Outperform NS $13.90 -6.26% -18.81% +12.56
ZFlark 30.46 3/13/2007 Outperform NS $13.90 -6.26% -18.81% +12.56
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. goldenboybenny1 < 20 7/18/2007 Outperform 1Y $15.40 -15.39% -26.60% +11.21
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackNorthlandSe 49.46 10/12/2007 Outperform NS $22.39 -41.80% -27.80% -14.00
TrackFeltlandCo 82.18 12/8/2006 Outperform NS $9.65 +35.03% -19.35% +54.37

Featured Broker Partners